Clinical trial

WB-EMS Effects on Cardiometabolic Risk Factors

Active, not recruiting · Not applicable · 1 countries · Registry ID NCT07406191

Active, not recruitingNot applicableInterventional

What this study is about

From the age of 50 onwards, there is a disproportionate decline in muscle strength, mass and function, which can be prevented or at least delayed by physical training. Unfortunately, many training programmes are very time-consuming and strenuous and are therefore not carried out consistently. Whole-body electromyostimulation (WB-EMS), a technology in which all major muscle groups are stimulated with an adjusted stimulation level, could be a time-effective and joint-friendly alternative. However, there are some contraindications to the widespread use of this technology, which are particularly common in middle-aged and elderly people. For example, high blood pressure, which affects more than half of men over the age of 50 in Germany, is considered a contraindication for WB-EMS training. However, this assessment is not very reliable; at least, acute WB-EMS application does not lead to an increase in blood pressure. In addition, there are no study results available for long-term WB-EMS application in people with high blood pressure. The present study particularly investigate whether and to what extent several weeks of WB-EMS training has an effect on resting blood pressure in people with mild blood pressure. Additionally, the effect of WB-EMS on other cardiometabolic risk factors and physical function will be addressed.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age50 Years to 70 Years

SexMale

Healthy volunteersNot accepted

ConditionHypertension, Metabolic Syndrome, Hypercholesterolemia, Hypertriglyceridemia, Overweight and Obesity

Full registry criteria

Inclusion Criteria: * Grade 1 hypertension: systolic 140 and/or diastolic 90 mmHg * overweight or obese (body mass index \> 25 kg/m2) Exclusion Criteria: * blood pressure-lowering pharmacologic therapy. * WB-EMS application and regular resistance exercise training * Conditions and illnesses that preclude intensive physical exertion * Severe cardiac arrhythmia * Heart failure * acute pulmonary embolism * acute myocarditis * severe hypertension, e.g. blood pressure \> 200 mmHg systolic and/or \>110 mmHg diastolic * Contraindications for bioimpedance analysis (e.g. pacemaker) * Contraindications for WB-EMS application (e.g. acute infections/fever, epilepsy)

Treatments and study arms

WB-EMS

Other

12 weeks of WB-EMS, 1.5x20 min/week

Control

Other

12 weeks without additional intervention and without life style changes

Primary outcomes

Resting blood pressureAt baseline and after 12 weeks of intervention

Changes of mean arterial blood pressure after 10 min of rest in a sitting position as assessed by an automatic sphygmomanometer

Metabolic syndromeAt baseline and after 12 weeks of intervention

Changes of the Metabolic Syndrome (MetS) as determined by the MetS-Z-Score

Study locations

2 locations were listed when this page was built. The first 40 are shown.

Faculty of Medicine, University of Tuebingen🇩🇪 Erlangen, Germany

Open map

Institute of Radiology, University Hospital Erlangen🇩🇪 Erlangen, Germany

Open map